Results 1 to 10 of about 2,546 (158)
Cross‐Neutralizing and Broadly Neutralizing Human Antibodies Against Nonenveloped Viruses
In this review article, Marchand et al. compare cross ‐ and broadly ‐neutralizing human antibodies against non ‐ enveloped viruses from several major families, discussing their structural characteristics, neutralization mechanisms and relevance for the development of antiviral vaccines and therapeutics.
Sarah Marchand +2 more
wiley +1 more source
After the first national-scale outbreak of Hand, foot, and mouth disease (HFMD) in China, a national surveillance network was established. Here we described the epidemiology and pathogenic profile of HFMD and the impact of EV-A71 vaccination on pathogen ...
Fenglan He +12 more
doaj +1 more source
Temperature and relative humidity showed nonlinear and lagged associations with HFMD risk in Guiyang (2022–2024), with the highest cumulative risk under the high‐temperature–high‐relative‐humidity condition. Higher estimated risks were observed among children under 3 years and scattered children, supporting the use of meteorological factors in HFMD ...
Xihong Zhang +5 more
wiley +1 more source
ABSTRACT Coxsackievirus A16 (CVA16) is a major causative agent of hand, foot, and mouth disease (HFMD), yet efficient virus‐like particle (VLP)–based vaccine development remains challenging due to enteroviral structural complexity and the cytotoxicity of the 3CD protease required for polyprotein processing.
Hyun‐Soo Kim +5 more
wiley +1 more source
By leveraging this homodimerization mechanism, molecular glues were rationally designed to induce dysfunctional 3A dimerization, thereby restoring antiviral RNAi. The optimal molecular glue, VTP‐32, demonstrated potent and pan‐enterovirus (groups A, B, D) antiviral effects.
Yuan Fang +13 more
wiley +1 more source
Antiviral activity of a crude extract of Thalassia testudinum Banks ex König against the human enteroviruses echovirus 9 and coxsackievirus A16 [PDF]
Context: Echovirus 9 (E9) and coxsackievirus A16 (CVA16) are etiological agents of aseptic meningitis and hand, foot, and mouth disease, respectively. Currently, there are no approved antiviral drugs against these viruses.
Liena de R. Ponce Rey +6 more
doaj +1 more source
Gingival and Periodontal Diseases and Conditions in Children and Adolescents: Consensus Report
ABSTRACT Background The objectives of this Focused Workshop were to update the epidemiology, aetiology, risk factors, diagnosis and management of gingival and periodontal diseases and conditions in children and adolescents, and to explore the applicability of the 2018 Classification in children and adolescents.
Iain Chapple +30 more
wiley +1 more source
Organoids: From Bench to Bedside Applications
Organoids, as a groundbreaking biomedical research platform, utilize adult stem cells (ASCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs) as sources. By integrating specific growth and differentiation signals within an extracellular matrix (e.g., Matrigel), organoids guide cells to self‐assemble into three‐dimensional ...
Kelin Li +6 more
wiley +1 more source
Hand, foot and mouth disease (HFMD) is highly prevalent in the Asia Pacific region, particularly in Vietnam. To develop effective interventions and efficient vaccination programs, we inferred the age-time-specific transmission patterns of HFMD serotypes ...
Yining Chen +19 more
doaj +1 more source
Fatal Coxsackievirus A-16 Pneumonitis in Adult
Coxsackievirus A-16 (CVA-16) is the agent of hand, foot, and mouth disease in children. We report a case of fatal pneumonitis in an adult due to a CVA-16 strain with a low (78.6%) rate of sequence homology with the reference strain.
François Legay +6 more
doaj +1 more source

